A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer

Name: A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer
License: Public Domain

Guangzhou Women and Children's Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

breast-cancer

breast cancer, estrogen receptor-positive, her2 low breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256883
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.